|Bid||59.64 x 1100|
|Ask||59.64 x 800|
|Day's Range||58.01 - 61.62|
|52 Week Range||50.50 - 100.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||209.93|
|Earnings Date||Mar 07, 2022 - Mar 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||111.67|
IRVINE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced the publication of its first ever “Ethos and Sustainability Report.” The report highlights Inari’s commitment to its ethos, and as part of that to environmental, social and governance (ESG) leadership. The report can be found on Inari’s website here. “I am proud to is
Inari Medical's (NARI) first-quarter results benefit from significant progress made across all of its growth drivers.
View more earnings on NARISee more from BenzingaQuidel Clocks More Than Three-Fold Jump In COVID-19 ProductsPacific Biosciences Clocks 14% Jump In Q1 RevenuesDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.